Alkylating Drug [EPC]

176283 reported adverse events

Drugs of this class: TEMOZOLOMIDE BUSULFAN MITOMYCIN THIOTEPA IFOSFAMIDE CYCLOPHOSPHAMIDE DACARBAZINE CHLORAMBUCIL CARMUSTINE LOMUSTINE LURBINECTEDIN

These side effects are most commonly reported by patients taking drugs of the Alkylating Drug [EPC] class:

# Side effect Count
0 FEBRILE NEUTROPENIA 13239
1 OFF LABEL USE 12604
2 NEUTROPENIA 10599
3 PYREXIA 9488
4 THROMBOCYTOPENIA 7627
5 DRUG INEFFECTIVE 7208
6 PRODUCT USE IN UNAPPROVED INDICATION 6909
7 NAUSEA 6862
8 DIARRHOEA 6305
9 PNEUMONIA 6255
See all common reactions for Alkylating Drug [EPC]

Drugs of the Alkylating Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ENGRAFTMENT SYNDROME 283 0.7057
1 CYSTITIS VIRAL 134 0.6569
2 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 625 0.5792
3 ENGRAFT FAILURE 130 0.5579
4 ACUTE GRAFT VERSUS HOST DISEASE 1988 0.5562
5 IDIOPATHIC PNEUMONIA SYNDROME 109 0.5533
6 VENOOCCLUSIVE DISEASE 1014 0.5523
7 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 229 0.5439
8 VIRAL HAEMORRHAGIC CYSTITIS 215 0.5335
9 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1009 0.5316
See all enriched reactions for Alkylating Drug [EPC]